Laboratoire d'Analyses Biologiques, Centre Hospitalier Esquirol, Limoges Cedex, France.
Alcohol Clin Exp Res. 2011 Nov;35(11):1966-73. doi: 10.1111/j.1530-0277.2011.01548.x. Epub 2011 Aug 16.
Diagnosing alcohol dependence is based on clinical signs and on the measured levels of biological markers of alcohol consumption. However, these markers are neither sufficiently sensitive and nor specific enough to definitively determine alcohol dependence. The neuroadaptive changes associated with alcohol dependence involve markers such as brain-derived neurotrophic factor (BDNF), which regulate neuronal plasticity. Serum levels of BDNF have been reported to decrease during alcohol dependence and may be restored to normal soon after alcohol is withdrawn. However, the long-term relationship between serum BDNF levels and abstinence status is unknown.
We investigated serum BDNF levels in 101 abstinent and relapsing alcohol-dependent subjects at the moment of hospitalization for alcohol withdrawal (M0) and 6 months later (M6) and compared them to the serum BDNF levels of 41 nondependent subjects. The BDNF levels of the alcohol-dependent subjects were compared to their serum gamma glutamyl transferase (GGT) levels, mean corpuscular volume (MCV) values, and their score on the Beck Depression Inventory (BDI) questionnaire.
Forty-four percent of the alcohol-dependent participants remained abstinent during the 6 months following alcohol detoxification. Serum BDNF levels of the abstinent group at M6 were significantly higher than those of the original group of alcohol-dependent subjects at M0 (p = 0.034). Only the abstinent group had higher BDNF levels than the control group (p < 0.001). Serum BDNF levels increased to a greater extent in the abstinent group than in the nonabstinent group (p = 0.016). No correlations were found between serum BDNF levels and GGT level, MCV value, or BDI score.
Our data confirm that serum BDNF levels do not correlate with either chronic alcohol consumption or peripheral toxicity but may be linked to neuronal aspects of alcohol consumption and dependence. The increased serum levels of BDNF may reflect the concomitant activation of BDNF synthesis that accompanies the neuronal remodeling triggered by alcohol withdrawal and suggests that BDNF synthesis may have a role in the long-term maintenance of abstinence. Monitoring the serum BDNF levels of alcoholics undergoing treatment could help to characterize alcohol dependence profiles and predict relapse.
酒精依赖的诊断基于临床症状和酒精消耗的生物标志物的测量水平。然而,这些标志物既不够敏感,也不够特异,无法明确确定酒精依赖。与酒精依赖相关的神经适应性变化涉及到脑源性神经营养因子(BDNF)等标志物,这些标志物调节神经元的可塑性。据报道,BDNF 的血清水平在酒精依赖期间下降,并可能在酒精戒断后很快恢复正常。然而,BDNF 血清水平与戒断状态的长期关系尚不清楚。
我们在酒精戒断住院治疗时(M0)和 6 个月后(M6),对 101 名酒精依赖且复发的受试者和 41 名非依赖的受试者进行了血清 BDNF 水平的检测,并将其与酒精依赖患者的血清 γ-谷氨酰转移酶(GGT)水平、平均红细胞体积(MCV)值和贝克抑郁量表(BDI)问卷的评分进行了比较。
在酒精解毒后 6 个月,44%的酒精依赖患者保持戒断。M6 时,戒断组的血清 BDNF 水平明显高于 M0 时的原始酒精依赖组(p=0.034)。只有戒断组的 BDNF 水平高于对照组(p<0.001)。戒断组的 BDNF 水平升高幅度大于非戒断组(p=0.016)。血清 BDNF 水平与 GGT 水平、MCV 值或 BDI 评分之间无相关性。
我们的数据证实,血清 BDNF 水平与慢性酒精消耗或外周毒性无关,但可能与酒精摄入和依赖的神经元方面有关。BDNF 血清水平的升高可能反映了伴随酒精戒断触发的神经元重塑而同时激活的 BDNF 合成,提示 BDNF 合成可能在长期维持戒断方面发挥作用。监测接受治疗的酗酒者的血清 BDNF 水平可能有助于确定酒精依赖谱并预测复发。